Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 102
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

The regulatory code of injury-responsive enhancers enables precision cell-state targeting in the CNS

The regulatory code of injury-responsive enhancers enab...

 36

Aged mice exhibit widespread metabolic changes but preserved major fluxes

Aged mice exhibit widespread metabolic changes but pres...

 60

Exercise-driven gut microbiota alterations enhance colonization resistance against methicillin-resistant Staphylococcus aureus

Exercise-driven gut microbiota alterations enhance colo...

 112